Sort
48,018 grants matching “immunotherapy”
A Human Antibody as an Immunotherapy for Cocaine Abuse
$444,299Andrew B Norman · P2d, Inc. · R44 · FY2006 · DA
DEVELOPMENT OF NOVEL SMALL-MOLECULE RB PROTEIN MODULATOR FOR OVARIAN CANCER IMMUNOTHERAPY
$444,293The Wistar Institute Of Anatomy And Biology · · FY2019 · Defense Health Agency
Tracking Therapy-Resistant Alterations in Childhood Acute Lymphoblastic Leukemia
$444,265Xiaotu Ma · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Project 2: Deciphering the Dynamic Evolution of the Tumor-Immune Interface
$444,255Stefani Spranger · Massachusetts Institute Of Technology · U54 · FY2025 · CA
FUNCTIONAL ANALYSIS OF PATHOGENIC AND PROTECTIVE PEANUT ALLERGEN-SPECIFIC HUMAN ANTIBODIES
$444,233Scott Dexter Boyd · Stanford University · R01 · FY2017 · AI
Multifunctional immunoPET tracers for pancreatic and prostate cancer
$444,176Anna M Wu · University Of California Los Angeles · R01 · FY2016 · CA
Achieving Therapeutic Antigent-Specific Tolerance in Type 1 Diabetes
$444,056Matthias G. Von Herrath · La Jolla Institute For Immunology · U01 · FY2009 · DK
Characterization of Pigmentary Disorders and Melanoma Targeting
$444,006Vincent J Hearing · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Immunobiology of Myeloid and Lymphoid Cells
$443,943Charles L Sentman · Dartmouth College · T32 · FY2020 · AI
B7-H1/PD-1 modulation in cancer therapy
$443,937Drew M. Pardoll · Johns Hopkins University · R01 · FY2014 · CA
Project 2 - Genomics of Allogeneic Transplantation.
$443,912John F Dipersio · Washington University · P01 · FY2020 · CA
T memory stem cells in cancer
$443,898Yiping Yang · Duke University · R01 · FY2018 · CA
T Cell Immunity in Endemic Burkitt Lymphoma
$443,858Ann M Moormann · Univ Of Massachusetts Med Sch Worcester · R01 · FY2012 · CA
Modeling immunity with a hybrid lymph node tissue-chip
$443,836Rebecca R Pompano · University Of Virginia · R01 · FY2018 · AI
SUPR Peptides to Inhibit Undruggable Cancer Target (PQ18)
$443,825Richard W Roberts · University Of Southern California · R01 · FY2015 · CA
Non-invasive Quantification of Dose-Exposure-Response of PD-L1 Therapeutics at the Tumor
$443,812Sridhar Nimmagadda · Johns Hopkins University · R01 · FY2019 · CA
Restoring Immune Tolerance in a Model of Multiple Sclerosis
$443,776Geoffrey D Keeler · University Of Florida · R01 · FY2025 · AI
Collaborative Innate-Adaptive Immune Regulation of Tumor Progression
$443,678Matthew F Krummel · University Of California, San Francisco · U01 · FY2011 · CA
Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities
$443,656Jlenia Guarnerio · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Reprogramming the Tumor Microenvironment in Ovarian Cancer
$443,654David D Schlaepfer · University Of California, San Diego · R01 · FY2020 · CA
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$443,645Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2021 · NS
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$443,645Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2019 · NS
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$443,645Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2020 · NS
Enhanced imaging and treatment of aggressive subtypes of prostate cancer
$443,607Martin G Pomper · Johns Hopkins University · R01 · FY2022 · CA
Engineering diverse commensal skin bacteria for targeted immunotherapy
$443,564Yiyin Erin Chen · Broad Institute, Inc. · R21 · FY2025 · CA